Market Scope: Ophthalmic Laser Market Expected to Total $400 Million in 2018

Global revenues for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total more than $400 million in 2018 and grow at a compound rate of 1.0 percent from 2018 to 2023, according to Market Scope estimates.

Factors expected to drive growth include expanding access to advanced medical treatment (retinal surgery and glaucoma treatment) in the developing world, rapid growth in the segment of the global population over age 65 in which there is a higher prevalence of retinal disease and glaucoma, and new technology that increases the effectiveness and uses of ophthalmic lasers.

In addition, new laser features and technology will provide manufacturers an opportunity to increase average prices.

These trends will be offset by an increasingly competitive global market for ophthalmic lasers, resulting in lower average selling prices for basic laser models, and by shifting treatments paradigms away from laser photocoagulation for retinal disease.

Market Scope has identified 18 manufacturers of the ophthalmic lasers and accessories; however, eight manufacturers account for almost 78 percent of estimated revenues. Market leaders include Topcon, Ellex, Lumenis, Iridex, Alcon, and Quantel Medical.

Market Scope’s “2018 Ophthalmic Laser Report: A Global Market Analysis for 2017 to 2023 (Photocoagulation, Photodisruption, and SLT).” was published in August.